Latest Ratios: P/E Ratio 8.3x · EV/EBITDA 5.1x · ROE 21.3%. (2012–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $25.8B | $29.9B | $26.0B | $16.2B | $15.9B | $26.4B | $20.5B | $24.3B | $17.5B | $30.9B | $30.2B |
| Enterprise Value | $26.0B | $30.1B | $26.8B | $17.9B | $19.8B | $32.6B | $24.8B | $32.0B | $32.1B | $40.1B | $41.0B |
| P/E Ratio → | 8.26 | 8.98 | 7.60 | 7.36 | 5.34 | 6.32 | 15.29 | 6.48 | 6.27 | 15.95 | 13.38 |
| P/S Ratio | 1.35 | 1.56 | 1.25 | 0.93 | 1.20 | 2.35 | 1.60 | 1.55 | 1.16 | 2.24 | 2.47 |
| P/B Ratio | 1.64 | 1.78 | 1.57 | 1.16 | 1.23 | 1.93 | 1.61 | 1.61 | 1.19 | 2.17 | 2.12 |
| P/FCF | 2.62 | 3.03 | 2.64 | 1.88 | 2.37 | 3.72 | 2.74 | 2.70 | 1.88 | 3.46 | 4.42 |
| P/OCF | 2.62 | 3.03 | 2.64 | 1.88 | 2.37 | 3.72 | 2.74 | 2.70 | 1.88 | 3.46 | 4.42 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.57 | 1.29 | 1.03 | 1.50 | 2.90 | 1.93 | 2.05 | 2.12 | 2.91 | 3.35 |
| EV / EBITDA | 5.07 | 5.85 | 5.32 | 5.32 | 4.52 | 5.53 | 11.36 | 6.09 | 8.14 | 11.20 | 10.82 |
| EV / EBIT | 5.63 | 6.51 | 5.88 | 6.16 | 4.99 | 5.92 | 13.78 | 6.54 | 8.82 | 12.06 | 11.48 |
| EV / FCF | — | 3.05 | 2.72 | 2.08 | 2.96 | 4.59 | 3.31 | 3.56 | 3.44 | 4.49 | 6.01 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 51.0% | 51.0% | 45.2% | 44.2% | 62.9% | 84.3% | 45.6% | 58.5% | 51.1% | 51.4% | 57.2% |
| Operating Margin | 24.2% | 24.2% | 21.9% | 16.7% | 30.0% | 49.0% | 14.0% | 31.3% | 24.0% | 24.2% | 29.2% |
| Net Profit Margin | 18.6% | 18.6% | 16.9% | 12.9% | 22.9% | 37.6% | 10.8% | 24.0% | 18.4% | 14.1% | 18.4% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 21.3% | 21.3% | 23.0% | 16.7% | 22.7% | 32.0% | 10.0% | 25.2% | 19.3% | 13.6% | 16.8% |
| ROA | 3.0% | 3.0% | 3.0% | 2.0% | 3.0% | 4.4% | 1.4% | 3.5% | 2.8% | 2.1% | 2.6% |
| ROIC | 10.8% | 10.8% | 11.0% | 7.6% | 10.8% | 14.6% | 4.2% | 10.0% | 7.4% | 7.2% | 7.5% |
| ROCE | 12.3% | 12.3% | 12.4% | 9.2% | 14.3% | 19.4% | 5.7% | 13.3% | 9.9% | 9.6% | 10.0% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.91 | 0.91 | 0.93 | 1.15 | 1.10 | 1.06 | 1.24 | 1.32 | 1.63 | 1.46 | 1.42 |
| Debt / EBITDA | 2.96 | 2.96 | 3.07 | 4.75 | 3.24 | 2.46 | 7.24 | 3.78 | 6.08 | 5.81 | 5.32 |
| Net Debt / Equity | — | 0.01 | 0.05 | 0.12 | 0.30 | 0.45 | 0.33 | 0.51 | 0.99 | 0.65 | 0.76 |
| Net Debt / EBITDA | 0.04 | 0.04 | 0.15 | 0.51 | 0.89 | 1.05 | 1.95 | 1.47 | 3.70 | 2.57 | 2.86 |
| Debt / FCF | — | 0.02 | 0.08 | 0.20 | 0.58 | 0.87 | 0.57 | 0.86 | 1.56 | 1.03 | 1.59 |
| Interest Coverage | 1.12 | 1.12 | 0.98 | 0.78 | 2.60 | 5.33 | 1.08 | 2.13 | 1.95 | 2.39 | 2.86 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.21 | 0.21 | 0.22 | 0.22 | 0.20 | 0.20 | 0.28 | 0.26 | 0.23 | 0.26 | 0.26 |
| Quick Ratio | 0.21 | 0.21 | 0.22 | 0.22 | 0.20 | 0.20 | 0.28 | 0.26 | 0.23 | 0.26 | 0.26 |
| Cash Ratio | 0.18 | 0.18 | 0.18 | 0.18 | 0.13 | 0.12 | 0.17 | 0.17 | 0.14 | 0.19 | 0.17 |
| Asset Turnover | — | 0.16 | 0.17 | 0.15 | 0.13 | 0.12 | 0.13 | 0.15 | 0.14 | 0.14 | 0.14 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 1.6% | 1.4% | 1.5% | 2.5% | 2.7% | 1.9% | 2.5% | 2.4% | 3.0% | 1.4% | 0.7% |
| Payout Ratio | 12.0% | 12.0% | 11.4% | 18.1% | 14.4% | 11.8% | 37.5% | 15.5% | 19.1% | 23.0% | 9.5% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 12.1% | 11.1% | 13.2% | 13.6% | 18.7% | 15.8% | 6.5% | 15.4% | 15.9% | 6.3% | 7.5% |
| FCF Yield | 38.1% | 33.0% | 37.8% | 53.1% | 42.1% | 26.9% | 36.5% | 37.1% | 53.3% | 28.9% | 22.6% |
| Buyback Yield | 11.4% | 9.9% | 3.9% | 6.9% | 20.9% | 10.9% | 4.8% | 14.9% | 10.7% | 4.8% | 1.6% |
| Total Shareholder Yield | 12.9% | 11.3% | 5.4% | 9.4% | 23.6% | 12.8% | 7.3% | 17.3% | 13.7% | 6.3% | 2.3% |
| Shares Outstanding | — | $358M | $401M | $424M | $483M | $569M | $591M | $674M | $747M | $800M | $832M |
Regulatory late fee compression
According to current market data, Synchrony trades at a forward P/E of 8.47, which appears to reflect a persistent complexity discount compared to broader consumer lenders, potentially underestimating the resilience of its specialized retail and healthcare credit platforms in the face of ongoing macroeconomic uncertainty.
The current valuation suggests the market is pricing in significant credit normalization risks, yet the low PEG ratio of 0.26 implies that investors may be overlooking the company's ability to maintain earnings growth through its unique Retailer Share Arrangement structure. This valuation gap warrants further investigation into whether the market is correctly discounting the long-term sustainability of its partner-centric business model.
Based on reported financial figures, Synchrony's ROIC has fluctuated between 1.4% and 4.2% over the last ten quarters, indicating that the company's ability to compound capital is heavily tethered to the cyclicality of credit loss provisions rather than pure operational efficiency gains.
The volatility in ROIC suggests that the firm's capital allocation is highly sensitive to the credit cycle, with the 2026Q1 figure of 2.1% highlighting the ongoing pressure from elevated charge-offs. Investors should monitor whether management can improve these returns as they pivot toward higher-margin, non-cyclical healthcare and pet insurance segments.
As reported in recent financial statements, Synchrony maintains a debt-to-equity ratio ranging from 0.85 to 1.15, suggesting a disciplined approach to balance sheet management that provides sufficient cushion to absorb potential shocks while supporting the ongoing funding requirements of its diverse credit card portfolio.
The interest coverage ratio, which has seen periods of compression toward 0.50, indicates that debt service comfort is sensitive to interest rate environments and credit performance. The current leverage profile appears adequate, but the reliance on deposit funding requires constant monitoring of deposit betas to ensure net interest margins remain protected.
Based on industry analysis, the efficiency ratio is frequently misapplied to Synchrony, as it fails to account for the unique Retailer Share Arrangement, which effectively nets out significant costs that would otherwise appear as operating expenses in a traditional banking or credit card business model.
Analysts often misinterpret the company's efficiency metrics by ignoring the RSA buffer, which acts as a shock absorber during periods of rising credit losses. A more accurate assessment of operational performance would require adjusting for these profit-sharing arrangements to reveal the true underlying cost structure of the lending platform.
Includes 30+ ratios · 14 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying SYF stock.
Synchrony Financial's current P/E ratio is 8.3x. The historical average is 9.6x. This places it at the 50th percentile of its historical range.
Synchrony Financial's current EV/EBITDA is 5.1x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 7.9x.
Synchrony Financial's return on equity (ROE) is 21.3%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 23.5%.
Based on historical data, Synchrony Financial is trading at a P/E of 8.3x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Synchrony Financial's current dividend yield is 1.55% with a payout ratio of 12.0%.
Synchrony Financial has 51.0% gross margin and 24.2% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.
Synchrony Financial's Debt/EBITDA ratio is 3.0x, indicating moderate leverage. A ratio between 2-4x is manageable but warrants monitoring.